期刊
NATURE REVIEWS DRUG DISCOVERY
卷 9, 期 2, 页码 107-115出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd3055
关键词
-
资金
- Swedish Research Council
- Swedish Cancer Foundation
- Karolinska Institute Foundation
- Torsten and Ragnar Soderberg's Foundation
- European Union [222741]
- European Research Council
Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue vasculature. Pharmacological manipulation of adipose tissue neovascularization by angiogenic stimulators and inhibitors might therefore offer a novel therapeutic option for the treatment of obesity and related metabolic disorders. This Perspective discusses recent progress in understanding the molecular mechanisms that control adipose tissue angiogenesis and in defining potential new vascular targets and approaches for the treatment of this group of diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据